Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, December 09, 2014
Today ZoBio (Leiden, The Netherlands) and Domainex Ltd. (Cambridge, UK) announce a collaboration with FORMA Therapeutics (Watertown, MA, USA) to provide NMR-based structural biology services for a substantial panel of FORMA drug targets.
read more
Thursday, November 20, 2014
SGS Life Science Services, the leading pharmaceutical analytical and bioanalytical contract solutions provider, today announced that it is to bring added-value to French clients’ drug development activities, as SGS’ biologics testing laboratory in ...
read more
Tuesday, November 18, 2014
SGS Life Science Services, the leading pharmaceutical clinical and bioanalytical contract solutions provider, today announced that its Biometrics group, one of the largest European data management, statistics and medical writing teams, became a ...
read more
Monday, November 17, 2014
Horizon Discovery Group plc (LSE: HZD) (Horizon), a leading provider of research tools to support translational genomics, , has today announced the formation of a new Scientific Advisory Board (SAB) for its Diagnostics Business Unit (Horizon ...
read more
Friday, November 14, 2014
Malvern’s rapidly growing analytical toolkit for all stages of the pharmaceutical and biopharmaceutical product lifecycle will be on show at this year’s AAPS Annual Meeting and Exposition, in San Diego, USA (San Diego Convention Center, 2 - 6 ...
read more
Friday, November 14, 2014
The Lubrizol Corporation announces an alliance between Lubrizol LifeSciences, a leading supplier of advanced materials for the healthcare industry, and
Particle Sciences, an integrated provider of drug development services.
read more
Thursday, November 13, 2014
Life Science Services, the leading bio/pharmaceutical analytical and bioanalytical contract solutions provider, today announced that it has been awarded cGMP accreditation for its newly added analytical laboratory, at its Livorno, Italy facility.
read more
Wednesday, November 12, 2014
announces that Biocon, one of Asia’s premier biotechnology companies, has just launched INSUPen® EZ in India. The INSUPen® EZ is a second generation pen and follows on the success of Biocon’s premier insulin delivery device INSUPen®. Under the terms ...
read more
Wednesday, October 08, 2014
SGS Life Science Services, the leading pharmaceutical analytical and bioanalytical contract solutions provider, today announced further investment in the French market, with a new facility in Villeneuve la Garenne. The new location, which will ...
read more
Tuesday, October 07, 2014
SGS Life Science Services, the leading pharmaceutical analytical and bioanalytical contract solutions provider, today announced the the completion of its fifth North American Life Science Services laboratory, in Carson, California.
read more
Roche (SIX: RO, ROG; OTCQX: RHHBY) and AmorChem L.P., a Montreal-based venture capital firm
investing in life science projects, today announced they have entered into a collaboration to discover
novel small molecule disease-modifying therapy for ...
read more
Today, ATS Labs, Inc. (ATS), majority owned by Ampersand Capital
Partners, announced that it acquired the assets of MicroTest Labs, Inc. (MTL) of Agawam, MA. The
acquisition of MTL is the first step in the strategy of ATS to expand its microbiology...
read more
Particle Sciences, Inc. has expanded its development
capabilities to accommodate the increasing demand for biopharmaceutical formulation and
analysis. According to Robert Becker, Vice President Biopharmaceutical Sales and Business
Development ...
read more
Alphora is pleased to announce that it has completed $2M in capital investments, adding two Flow Chemistry platforms
and additional process chemistry and analytical technologies to its toolbox. These additions represent a significant
investment for...
read more
CMC Biologics, Inc., a global leader in process development and contract manufacturing, today announced that it has entered in to a Commercial Supply Agreement with Portola Pharmaceuticals, a biopharmaceutical company for the development of andexanet...
read more